#StudyDesign

Jan R. Boehnkejrboehnke
2025-06-20

Thank you to and Behavioral Medicine @unibern for writing a post about the recent Summer Course 2025, “Contemporary Evaluation of Interventions: Mobile, Digital, and Pragmatic”
linkedin.com/posts/gesundheits

Jan R. Boehnkejrboehnke
2025-06-16

A well-justified epistemological foundation is a key requirement for a :
sciencedirect.com/science/arti

The team argues that encourage researchers to reflect on and disclose key assumptions and methodological choices in such studies.

Jan R. Boehnkejrboehnke
2025-06-11

Co-developed at and
"A Toolkit for Building a Collective of Older Adult Researchers"
sfu.ca/starinstitute/about/ins
(COAR)

"A practical resource for engaging older adults as active partners in community-based research"

Jan R. Boehnkejrboehnke
2025-06-03

Research participants being fully informed about the research and to provide their voluntary consent to participate is a cornerstone of ethical research practice.

Secondary school pupils in Cameroon explored how to engage with consent principles, main focus were benefits and risks of participation, , and confidentiality
journals.sagepub.com/doi/full/

Jan R. Boehnkejrboehnke
2025-04-10

Mirjam Stieger (Lucerne Uni) and I are invited to present
"Contemporary of Interventions: Mobile, Digital, and Pragmatic"
at @unibern
bbs.unibe.ch/training/summer_c

This is the annual Summer Course of the Doctoral Program Brain and Behavioral Sciences, and comprises a mixture of keynotes, masterclasses, hidden curriculum etc.

I am very much looking forward to it, and also very honoured to be invited once again to Bern to train !

🧪 🛟 In this CPH Focus: Explore the essentials of randomized controlled trials (RCTs)—the gold standard in experimental study designs for evaluating interventions—crucial for public health and clinical research. Link: buff.ly/48GZbnT #CPH #PublicHealth #StudyDesign #EpiSky #MedSky
buff.ly/48GZbnT

Jan R. Boehnkejrboehnke
2025-01-27

Tutorial paper illustrating how to develop planned contrasts (as an alternative to comparisons) in , including empirical examples with reproducible data:
journals.sagepub.com/doi/full/

2024-12-09

🎄Day 9🎄Master #fNIRS Research with Proven #BestPractices 📘
Stay informed and enhance the quality of your studies by following these best practices for fNIRS research. From study design to data reporting, this guide provides valuable insights to help you publish impactful research.
🎁✨ Ready to refine your approach? doi.org/10.1117/1.NPh.8.1.0121

#ArtinisAdventCalendar #Research #StudyDesign

2024-07-10

pubmed.ncbi.nlm.nih.gov/384018 Recreational MDMA doses do not elicit hepatotoxicity in HepG2 spheroids under normo- and hyperthermia (de Oliveira, et al, 2024) #mdma #fda #psychedelic #psychedelics #psychedelicresearch #fda #studydesign #litreview #ptsd #psychedelicassistedtherapy #mdmaassistedtherapy #entactogens #neuroscience

2024-07-09

pubmed.ncbi.nlm.nih.gov/389794 Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review (Liu, et al, 2024) #ketamine #pain #depression #ptsd #psychedelic #psychedelics #psychedelicresearch #psychedelicmentalhealth #mentalhealth #veterans #chronicpain #fda #studydesign #litreview #ketamineassistedtherapy #psychedelicassistedtherapy

2024-07-02

psychedelicmentalhealth.net/ne Neural correlates and subjective experiences in meditation vs psychedelics, including ketamine (Preliminary Lit Review)
A preliminary, evolving review of the literature. (Ongoing Draft) | Psychedelic Institute of Mental Health & Family Therapy #meditation #psychedelics #ketamine #ayahausca #lsd #psilocybin #dmt #neuroscience #Psychedelic #Litreview #research #studydesign #fda #mdma #psychedelicassistedpsychotherapy #cognitivebehavioraltherapy

2024-06-22

#Psilocybin Versus #ketamine in Treatment-Resistant #depression (PSIKET_001) #clinicaltrial #studydesign #psychedelics #psychedelic #psychedelicresearch #fda #mdma Now recruiting in #czechrepublic

ClinicalTrials.gov ID NCT05383313
Sponsor: National Institute of Mental Health, Czech Republic clinicaltrials.gov/study/NCT05 — This study does direct comparison with an active placebo midazolam which is not an #antidepressant

Ketamine vs psilocybin clinical trial for depression
2024-06-22

clinicaltrials.gov/study/NCT05 Emory University plans #fda Phase 2 study of #mdma plus a type of behavioral #psychotherapy called Exposure Therapy for the treatment of #ptsd — This study is unrelated to the MAPS/Lykos new drug application for #mdmaassistedtherapy and a reminder #psychedelic #research is robust and ongoing. #studydesign should include blinding with #ketamine and comparison to #cognitivebehavioraltherapy #psychedelics

Client Info

Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst